On November 1, 2023 in Astana within the framework of the official visit of the President of France Emmanuel Macron to Kazakhstan there was signed an agreement on cooperation, license and supply between JSC “National Holding “QazBioPharm” and Boehringer Ingelheim Animal Health.
The signing of the Agreement regulates the main arrangements of the parties on the terms of partnership on the production of vaccines on the production site of the plant OtarBioPharm LLP (a subsidiary of the Holding) using Boehringer Ingelheim technologies.
Under the terms of the partnership, Boehringer Ingelheim will supply not only raw materials for FMD vaccine production, but also technical and scientific support of the production process.
This partnership will develop industrial know-how in the production of high quality FMD vaccines and will help Kazakhstan to establish its production and distribution.
As a result of the cooperation, Kazakhstan has the opportunity to become FMD-free and meet OIE standards, which will allow the country to export meat to foreign markets, including EU countries.